TAKP34:BVMF
Takeda Pharmaceutical Co Ltd BDR
90,54Â BRL
0,00%
(0,00) 1D
6 tet, 3:21:39 m.d., GMT-3 · BRL
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për TAKP34...
Kapitalizimi i tregut
58,97Â mld
Vëllimi mesatar
36,00
Vëllimi
0,00
Maksimumi 52-javor
102,65Â BRL
Minimumi 52-javor
70,80Â BRL
Aksionet në qarkullim
1,60Â mld
Numri i punonjësve
47 mijë
Kapitalizimi i tregut
58,97Â mld
Vëllimi mesatar
36,00
Vëllimi
0,00
Maksimumi 52-javor
102,65Â BRL
Minimumi 52-javor
70,80Â BRL
Aksionet në qarkullim
1,60Â mld
Numri i punonjësve
47 mijë
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
AD HOC NEWS
·
8 orë më parë
Analysts raise target for Takeda Pharmaceutical stock to JPY 5,800
Simply Wall Street
·
21 orë më parë
Should Phase 3 Psoriasis Win Require Action From Takeda Stock Investors?
Profili
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda. In 2026, Julie Kim was noted in a news item as "CEO-elect". Wikipedia
Rreth Takeda Pharmaceutical Co Ltd BDR
Drejtori ekzekutivChristophe Weber | Christophe Weber
Punonjësit47 mijë
Themeluar më12 qer 1781
Selia-
Sektori-
Uebsajtitakeda.com